Ownership history in Squarepoint Ops LLC · 13 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in TAKEDA PHARMACEUTICAL CO LTD (TAK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 203,810 | +159,705 | +362.1% | 0.00% | $3.0M | $14.64 |
| 2025 Q2 | REDUCED | 44,105 | -19,528 | -30.7% | 0.00% | $682K | $15.46 |
| 2025 Q1 | REDUCED | 63,633 | -1,041 | -1.6% | 0.00% | $946K | $14.87 |
| 2024 Q3 | REDUCED | 64,674 | -2,086 | -3.1% | 0.00% | $920K | $13.90 |
| 2024 Q1 | ADDED | 66,760 | +41,656 | +165.9% | 0.00% | $927K | $13.27 |
| 2023 Q4 | REDUCED | 25,104 | -23,006 | -47.8% | 0.00% | $358K | $13.36 |
| 2023 Q1 | ADDED | 48,110 | +23,347 | +94.3% | 0.00% | $793K | $15.43 |
| 2021 Q4 | ADDED | 24,763 | +11,487 | +86.5% | 0.00% | $338K | $12.76 |
| 2021 Q2 | REDUCED | 13,276 | -4,753 | -26.4% | 0.00% | $223K | $15.76 |
| 2021 Q1 | REDUCED | 18,029 | -19,405 | -51.8% | 0.00% | $329K | $17.09 |
As of 2025 Q4 — sorted by position size